Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01283451 · ClinicalTrials.gov registry record

Ability of Near Infrared Spectroscopy to Isolate Compartments of the Extremity

A clinical trial, sponsored by J&M Shuler.

Completed
Registry status
63
Enrollment target

NCT01283451: Completed study, sponsored by J&M Shuler.

NCT01283451 is a clinical trial that has completed, run by J&M Shuler. The registered enrollment target is 63 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01283451 has completed, sponsored by J&M Shuler.

COMPLETED
Registry status
63 participants
Enrollment target

Study Summary

Near infrared spectroscopy (NIRS) provides a non-invasive means of continuously monitoring tissue oxygenation, which may be useful for diagnosis of acute compartment syndrome (ACS). Placement of these sensor pads on the surface of the skin must be such that light penetrates the intended compartment without inadvertently obtaining measurements of an adjacent compartment. The objective of this study is to examine whether the NIRS measurements of each compartment truly represent the tissue perfusion of the intended compartment, as indicated by the predictable decrease in muscle oxygenation of a given compartment in response to muscle fatigue. The investigators hypothesize that the tissue oxygenation values of the stimulated compartment will significantly decrease following muscle stimulation, indicating that the intended muscle compartment was successfully isolated. Additionally, the investigators hypothesize that NIRS values of unstimulated muscle compartments will not change from baseline.

Primary Outcome

NIRS values will be measured before and after muscle fatigue

Interventions

  • BEHAVIORAL Muscle contraction

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2010-01
Est. Completion 2016-12
J&M Shuler

5 total trials

What the finished NCT01283451 record still lists

NCT01283451 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 63 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Muscle contraction is the first listed.

NCT01283451 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01283451 about?

NCT01283451 is a clinical study titled "Ability of Near Infrared Spectroscopy to Isolate Compartments of the Extremity". Near infrared spectroscopy (NIRS) provides a non-invasive means of continuously monitoring tissue oxygenation, which may be useful for diagnosis of acute compartment syndrome (ACS). Placement of these sensor pads on the surface of the skin must be such that light penetrates the intended compartment ...

What is the current status of trial NCT01283451?

This trial is currently completed. The enrollment target is 63 participants. The study started on 2010-01. Estimated completion is 2016-12.

What interventions are being tested in trial NCT01283451?

The interventions under investigation include: Muscle contraction (BEHAVIORAL).

Who is sponsoring clinical trial NCT01283451?

This trial is sponsored by J&M Shuler, which has 5 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03383575 · 63 participants · Phase 2

    Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome

  • NCT04870944 · 63 participants · Phase 1

    CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • NCT05031897 · 63 participants · Phase 2

    Two Step Haplo With Radiation Conditioning

  • NCT05312671 · 63 participants · Phase 2

    Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01283451, the US trial registry maintained by the National Library of Medicine. NCT01283451 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.